百奥赛图-B2025年度报告

百奧賽圖北京醫藥科技股份有限公司Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (A joint stock company incorporated in the People’s Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司） Stock code股份代號：2315 CONTENTS 2Corporate Information6Definition18Chairman’s Statement21Management Discussion and Analysis60Directors, Supervisors and Senior Management68Corporate Governance Report94Directors’ Report141Independent Auditor’s Report148Consolidated Statements of Profit or Loss andOther Comprehensive Income149Consolidated Statements of Financial Position151Consolidated Statements of Changes in Equity153Consolidated Cash Flow Statements155Notes to the Consolidated Financial Statements260Financial Summary Corporate Information CHINESE NAME()ENGLISH NAMEBiocytogen Pharmaceuticals (Beijing) Co., Ltd.* Biocytogen Pharmaceuticals (Beijing)Co., Ltd.* LEGAL REPRESENTATIVEDr. Shen Yuelei CHAIRMAN OF THE BOARDDr. Shen Yuelei HEAD OFFICES AND PRINCIPAL PLACE OFBUSINESS IN CHINA 12 12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District, BeijingPRC REGISTERED OFFICE 12 12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District, BeijingPRC PRINCIPAL PLACE OF BUSINESS IN HONGKONG 24840 40th Floor, Dah Sing Financial CenterNo. 248 Queen’s Road EastWanchaiHong Kong Corporate Information BOARD OF DIRECTORS Executive Directors Dr. Shen Yuelei(Chairman, Chief Executive Officer and General Manager)Dr. Ni JianDr. Zhang Haichao(Senior Operation Director of Animal Center)(resigned on December 10, 2025) 202512 10 Non-executive Directors 202512 3120262 12 Mr. Wei Yiliang(resigned on December 31, 2025)Dr. Zhou KexiangMs. Zhang LeidiDr. Liu Hongkang(appointed on February 12, 2026) Independent Non-executive Directors Mr. Hua FengmaoDr. Yu ChangyuanMs. Liang Xiaoyan EMPLOYEE DIRECTOR 202512 10 Ms. Li Yan(appointed on December 10, 2025) SUPERVISORS(1) (1) Ms. Li YanMs. Sun ChunliDr. Yao Jiawei AUDIT COMMITTEE 202512 3120262 12 Ms. Liang Xiaoyan(Chairman)Mr. Hua FengmaoDr. Yu ChangyuanMr. Wei Yiliang(resigned on December 31, 2025)Dr. Liu Hongkang(appointed on February 12, 2026) REMUNERATION AND EVALUATIONCOMMITTEE Mr. Hua Fengmao(Chairman)Ms. Liang XiaoyanDr. Yu ChangyuanDr. Ni Jian Corporate Information NOMINATION COMMITTEE Dr. Yu Changyuan(Chairman)Mr. Hua FengmaoMs. Liang XiaoyanDr. Shen Yuelei STRATEGY DEVELOPMENT COMMITTEE 202512 3120262 12 Dr. Shen Yuelei(Chairman)Dr. Zhou KexiangMr. Wei Yiliang(resigned on December 31, 2025)Ms. Zhang LeidiDr. Liu Hongkang(appointed on February 12, 2026) JOINT COMPANY SECRETARIES Mr. Wang YongliangMs. Au Wai Ching(fellow member of The Hong Kong CharteredGovernance Institute and The Chartered Governance Institute inthe United Kingdom) AUTHORIZED REPRESENTATIVES Dr. Shen YueleiMs. Au Wai Ching AUDITOR 108 KPMGPublic Interest Entity Auditor registered in accordance withthe Accounting and Financial Reporting Council Ordinance8th Floor, Prince’s Building10 Chater RoadCentral, Hong Kong PRINCIPAL BANKS 2 China Construction Bank Beijing Economic and TechnologicalDevelopment Zone Sub-branchNo. 2, Jingyuan North StreetDaxing DistrictBeijing, PRC 881 China Merchants Bank, Beijing Yizhuang Sub-branch1/F, Building 8, Libao PlazaNo. 8 Ronghua Middle RoadDaxing DistrictBeijing, PRC Corporate Information H H SHARE REGISTRAR 1617 Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong LEGAL ADVISERS TO HONG KONG LAW 3A10 Davis Polk & Wardwell10th Floor, The Hong Kong Club Building3A Chater Road, Hong Kong STOCK CODE H02315A688796 Stock code of H Shares: 02315Stock code of A Shares: 688796 COMPANY WEBSITE http://www.biocytogen.com.cn http://www.biocytogen.com.cn CONTACT INFORMATION FOR INVESTORS 010-56967601010-56967666-8067ir@biocytogen.com.cn Tel.: 010-56967601Fax: 010-56967666-8067Email: ir@biocytogen.com.cn (1)20251210A Note: (1)Sincethe completion of the Issue of A Shares and the listing on theSTAR Market on December 10, 2025, the Company has no longer had aSupervisory Committee. Definition “A Share(s)” 2019624Beijing Baiao Changsheng Technology Development Center (LimitedPartnership)* (()), a limited partnershipestablished in the PRC on June 24, 2019, of which Dr. Shen is the solegeneral partner, and a member of a Concert Party “CG Code” Definition “Company”, “our Company” or“Biocytogen” “Employee(s)” any full-time employee (excluding any Excluded Employee) of anymember of the Group (i)1(ii)(i) at the time of the proposed grant of an Award, any Employee whoseservice in the Group does not exceed 1 year from the expiry date of hisprobationary period as stated in his employment contract with the Group,except as otherwise determined by the Board at its absolute discretionon a case by case basis, or (ii) any Employee who is resident in a placewhere the award of the Awarded Shares and/or the vesting and transfer ofthe Awarded Shares pursuant to the terms of the Scheme is not permittedun